Skip to main content
TipRanks
Go Ultimate75% OFF

Munich Reinsurance (0KFE) AI Stock Analysis

15 Followers
GB:0KFE

Munich Reinsurance

(LSE:0KFE)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Profit and revenue growthMunich Re has demonstrated strong earnings progression alongside a sharp acceleration in reported revenue. This indicates improving scale and operating performance across the group, giving the company greater capacity to reinvest, absorb claims volatility, and sustain profitable growth over the coming quarters.
Negative Factors
Cash-flow volatilityAlthough recent cash flow remains positive, the pronounced swings show that reported earnings do not translate evenly into cash generation. Claims timing, investment movements, and working-capital effects can therefore reduce financial flexibility, complicate capital planning, and make cash-based performance less predictable over the medium term.

Munich Reinsurance (0KFE) vs. iShares MSCI United Kingdom ETF (EWC)

-20%-10%0%10%20%30%GB:0KFE+13.80%EWC+19.77%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 76.79B
Dividend Yield
4.23%
Average Volume (3M)
64.05K
Price to Earnings (P/E)
10.6
Beta (1Y)
0.69
Revenue Growth
0.06%
EPS Growth
38.83%
Country
UK
Employees
44,595
Sector
General
Sector Strength
55
Industry
Insurance - Reinsurance

Munich Reinsurance Business Overview & Revenue Model

Company Description

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. The company operates through six segments: Life and Health Reinsurance, Property-Casualty Reinsurance, Global Specia...

Munich Reinsurance Earnings Call Summary

Earnings Call Date:Nov 12, 2026(Q3-2026)|% Change Since:3.16%|Next Earnings Date:Feb 25, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Munich Re reported a EUR 1.7 billion Q3 result, EUR 5.7 billion after nine months, raised full-year guidance to EUR 6.6 billion, and expects to beat full-year guidance in multiple reinsurance businesses. Operational performance, investment income, ERGO results, capital strength, and strategic growth initiatives were broadly favorable. The main challenges were lower ERGO investment returns, rising normalized P&C combined-ratio pressure, negative renewal volume trends, expected downward pricing pressure, specific disability assumption updates, and the decline in the Solvency II ratio, but these did not outweigh the positive performance described during the call.

Positive Updates

Strong Q3 and Nine-Month Net Result
Munich Re reported a Q3 net result of EUR 1.7 billion, described as another particularly strong quarter. The net result reached EUR 5.7 billion after nine months, putting the company firmly on track to exceed its annual profit target for the sixth consecutive year.

Negative Updates

Lower ERGO Investment Return
Global bond yields rose sharply in Q3, reducing the fair value of ERGO's fixed-income investments and directly burdening its investment result. ERGO's return on investment was relatively low at 2.1%, although management said the P&L impact was relatively small because of policyholder participation.

Company Guidance

For full-year 2026, Munich Re raised its net result guidance to EUR 6.6 billion, with the increase coming from the reinsurance business field, and expects to exceed its annual profit target for the sixth consecutive year; life and health reinsurance remains on track for full-year guidance of EUR 1.9 billion, P&C reinsurance is expected to beat its full-year guidance after a headline actual combined ratio of 72.2% after nine months, and Global Specialty Insurance is expected to beat its full-year guidance after achieving a combined ratio below 86% for the first nine months, while ERGO International’s P&C combined ratio of 89% met full-year guidance. The group’s revenue is “now holding strong and even looks as if it may exceed those levels that we set,” the 18% outlier guidance for this year is “probably higher than it needs to be,” and normalized combined ratio upward pressure will continue in Q4, with the 11.5% discounting benefit in Q3 not considered “the new normal”; the sustainable running yield was indicated as “something more like 3.7%, with maybe potential for some upwards drift,” and the financial outlook for 2027 will be disclosed on December 10th.

Munich Reinsurance Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

GB:0KFE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:TLXDE:TLX76OutperformEUR 33.79B12.9625.67%2.75%2.06%15.31%
DE:HNR1DE:HNR172OutperformEUR 35.67B3.8767.35%4.24%1.91%12.48%
DE:NBG6DE:NBG657NeutralEUR 1.42B31.595.09%1.62%-0.95%―
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
DE:WUWDE:WUW55NeutralEUR 1.24B9.212.73%4.89%――

* General Sector Average

Performance Comparison

-10%0%10%20%GB:0KFEDE:HNR1DE:TLXDE:WUWDE:NBG6Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0KFE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0KFEMunich Reinsurance587.4063.4712.11%
DE:HNR1Hannover Rueck SE (UK)296.8050.2320.37%
DE:TLXTalanx AG132.8024.3622.46%
DE:WUWWuestenrot & Wuerttembergische13.34-0.03-0.22%
DE:NBG6Nuernberger Beteiligungs AG Class B123.505.504.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.